265;
. . E i n s t e l n Coll. Med., Montefiore Hosp. 6 Med. C t r . , Dept. Ped., New York.
PCA i s used o f t e n t o t r e a t Pb t o x i c i t y a f t e r a d m i n i s t r a t i o n ( CaNa,EDTA. Since the source of Pb mobilized by PCA comes from bone, t h i s study was undertaken t o d e f i n e f u r t h e r PCA's a c t i o n s on bone, a f t e r demonstration of a r e a d i l y mobile compartment of s k e l e t a l Pb i n v i t r o r e g u l a t e d l i k e bone mineral. Pregnant r a t s were i n j e c t e d w i t h 500pCi of '033pb and 2OOpCi of 4 5~a on the 181 day of pregnancy. On day ii19, p a i r e d f e t a l bones were c u l t u r e d i a chemically d e f i n e d rnedium t o which PCA, p a r a t h y r o i d hormone (PTH) o r 1,25-dihydroxyvitamin D, ( 1 , 2 5 [ 0~] ,~, ) were added. For 48 t o 120H, bones were maintained i n experimental media ( 5 l ) ; a r the amount of "*b r e l e a s e d i n t o the E M ' S was compared t b t h a t r e l e a s e d i n t o t h e a p p r o p r i a t e c o n t r o l media (CM). The r e s u l t s ( * = p< . O l , d i f f e r e n t from 1.00) were e x p r e s s f d a s cpm EM/CM r a t i o s : PCA (l.OOmM)1.96?.04*; PCA+PTH 6.30+.14-'-; PCA+1,25(OH D, 5.89r.10?:. I n c r e a s i n g and d e c r e a s i n g medium l e v e l s of Ca and phosphate drpressed and cnhanced 23'Pb r e l e a s e , r e s p e c t i v e l y , while no e f f e c t on 4 5~a r e l e a s e was seen with PCA alone. PCA, compared t o equimolar amounts of CaNa,EDTA, was 1000 times l e s s p o t e n t i n c h e l a t i n g "OdPb; and PCA'S maximum e f f e c t w a s t r a n s i e r vs. CaNa,EDTA ( 4 8 vs. 120H).
These d a t a i n d i c a t e t h a t PCA, l i k e CaNa,EDTA, produce "03pb r e l e a s e from a r a p i d l y mobile compartment of bone Pb; but PCA's a c t i o n was l e s s p o t e n t and s h o r t -l i v e d compared t o CaNa,EDTA.
S a e n e r , A . R i f k i n c J . P a r e i r a , L . S . L e v i n e , d
U n i v e r s i t y M e d i c a l C o l l e g e , New Y o r k .
The r a t e of disappearance of a n t i p y r i n e from t h e plasma i s a were evaluated i n 4 p a t i e n t s . The h a l fl i f e of a n t i p y r i n e ( t i ) was measured before and a f t e r drug therapy i n each p a t i e n t . The mean t', was not a f f e c t e d by admini s t r a t i o n of dexamethasone (tl, 7.6 t 1.14 h versus 7.8 t 0.84 h ) . 
W e conclude t h a t t h e s h o r t tern) a d m i n i s t r a t i o n of dexamethasone and ACTH with ensuing s t i~l l u l a t i o n of endogenous g l u c o c o r t i c o i d
production i s u n l i k e l y t o produce c l i n i c a l l y s i g n i f i c a n t changer i n t h e r a t e of drug metabolism.
NETlLMlClN PHARMCOLOGY I N PEDIATRIC PATIEKTS.
Hamilton, and L. R i f f .
1 Unl v. of I l l . H o s p i t a l , Dept. of Peds and Med.Chica~ N e t i l m i c i n , an aminoglycoside w i t h spectrum s i m i l a r t o gent a m i c i n , i s l e s s t o x i c than gentamicin in a n i m a l s , and i s s a f e and e f f i c a c i o u s in a d u l t s . We s t u d i e d n e t i l m i c i n in 40 i n f a n t s and c h i l d r e n w i t h suspected o r proved b a c t e r i a l i n f e c t i o n . Most p a t i e n t s a l s o received a p e n i c i l l i n . In newborns, one hour a f t e the f i r s t I M dose a peak level of 2.9+.4 mcg/ml was achieved;
T-A averaged 3.85 h. The peak l e v e l s a t t a i n e d a f t e r the f i r s t dose were suboptimal. However, l e v e l s on the 2nd d of therapy were 4.52.6 mcg/ml and on day 7-10, the peak level was 4 . 6~1 . 0 mcg/ml. In i n f a n t s =. 7 d. of a g e , T-$ averaged 3.0 h. Serum c o n c e n t r a t i o n curves on day 7-10 were higher than those observed a f t e r the f i r s t dose but s i g n i f i c a n t drug accumulation d i d not occur between the 2nd and l o t h d. Peak values d i d not vary w i t h age. The time t o reach t h e trough level was 11 h in i n f a n t s C 1 wk, but 7 h in p a t i e n t s ? 1 wk. Anuric p a t i e n t s had prolonged e l e v a t i o n of serum c o n c e n t r a t i o n s . Measurable n e ti l m i c i n l e v e l s were f.ound in CSF, a s c i t e s f l u i d , kidney, muscle and spleen. E E G o r pure tone audiometry was normal in a l l 26 p a t i e n t s t e s t e d . No renal a b n o r m a l i t i e s were a t t r i b u t a b l e t o n e t i l m i c i n use. E o s i n o p h i l i a occurred in 17 p a t i e n t s . Oocumente b a c t e r i a l i n f e c t i o n s were s u c c e s s f u l l y t r e a t e d w i t h n e t i l m i c i n alone ( 4 ) o r in combination w i t h o t h e r a n t i b i o t i c s ( 9 ) . In l i g h t of t h e p r e d i c t a b i l i t y of serum l e v e l s , e f f i c a c y , and minimal t o x i c i t y , a c o n t r o l l e d comparative s t u d y of n e t i l m i c i n w i t h o t h e r aminoglycosides should be undertaken. NEONATAL WITHDRAWAL. E x S e l l , Nancy Bra P e d i a t r i c s and Hope Center, Tucson.
I n f a n t s of 23 mothers on a methadone maintenance program were observed f o r evidence of drug withdrawal. Ten i n f a n t s had no withdrawal; 13 had withdrawal symptoms and 9 r e q u i r e d t r e a t m e n t .
The mothers' h i g h e s t methadone doses ranged from 74-80 mg, and t h e i r lowest doses ranged from 0-40 mg. Mothers who i n t h e t h i r d t r i m e s t e r had 113 o r more of weekly random u r i n e s p o s i t i v e f o r h e r o i n o r who were s u s p e c t e d by t h e c e n t e r of h e r o i n use ( e . g , r e f u s a l t o have u r i n e t e s t e d ) , were d e f i n e d a s h e r o i n user I n the 1 3 mothers n o t u s i n g h e r o i n , only 3 i n f a n t s (23%) had withdrawal symptoms. I n t h e 10 mothers u s i n g h e r o i n , a l l 10 inf a n t s had withdrawal symptoms. This d i f f e r e n c e i s s i g n i f i c a n t a t p<.001.
When t h e m o t h e r ' s methadone dose a t d e l i v e r y was considered, t h e i n f a n t s of 3 mothers who were on 1 5 mg o r more of methadone and whose methadone dose had been i n c r e a s e d b e f o r e d e l i v e r y , a l l e x h i b i t e d withdrawal symptoms. I n c o n t r a s t , none of t h e i n f a n t s of 10 mothers who were on <15 mg. methadone and had had no inc r e a s e i n dose b e f o r e d e l i v e r y showed withdrawal symptoms. Conclusion: Mothers maintained on methadone d u r i n g pregnancy had a g r e a t l y i n c r e a s e d r i s k of d e l i v e r i n g a symptomatic i n f a n t i f they were a l s o t a k i n g h e r o i n during t h e t h i r d t r i m e s t e r , o r i f t h e methadone dosage had been i n c r e a s e d p r i o r t o d e l i v e r y . 
Phenobarbital may produce s i g n i f i c a n t b e h a v i o r a l a l t e r a t i o n s and c o g n i t i v e d e f i c i t s i n c h i l d r e n and impaired b r a i n growth i n deve. loping animals. We have i n v e s t i g a t e d t h e long term consequences of p h e n o b a r b i t a l a d m i n i s t r a t i o n on a c t i v i t y l e v e l s and c o g n i t i v e performance i n normal developing r a t pups and l i t t e r m a t e s r e c e i v -
ing i n t r a c i s t e r n a l i n j e c t i o n s of 6-hydroxydopamine (6-OHDA) a t 5 days o f age.
I n normal r a t pups, p h e n o b a r b i t a l reduced a c t i v i t y l e v e l s a t 26 days of age ( p < 0 . 0 5 ) , b u t d i d n o t a f f e c t avoidance performance. However, i n 6-OHDA r a t pups p h e n o b a r b i t a l reduced a c t i v i t y a t 19 days (p < 0.001) increased a c t i v i t y a t 26 days of age (p <0.05) and s i g n i f i c a n t impaired both T-maze and s h u t t l e box performance (p <0.001).
Phenobarbital c o n c e n t r a t i o n s a t 35 days (EMID Technique) averaged 15.5 + 2.01 and 20.2 + 2.76 ~g / m : i n c o n t r o l and 6-OHDA r a t pups r e s p e c t i v e l y ( p ) 0 . 0 5 ) . Body weight was s i g n i f i c a n t l y reduced i n 6-OHDA r a t pups from day 8 but t h e r e were never s i g n i f i c a n t d i f f e r e n c e s between phenobarbit a l and c o n t r o l animals. Brain dopamine c o n c e n t r a t i o n s i n 6-OHDP animals averaged 35.5% of l i t t e r m a t e c o n t r o l s and d i d not d i f f e r between phenobarbital and c o n t r o l animals. These f i n d i n g s supp o r t t h e n o t i o n t h a t p h e n o b a r b i t a l a d m i n i s t r a t i o n may a d v e r s e l y a f f e c t a c t i v i t y and c o g n i t i v e performance i n t h e developing m a m l i a n b r a i n and suggest c a u t i o n i n t h e r o u t i n e use of t h i s a e e n t .
l~n i v e r s i t~ of Pennsylvania, P h i l a d e l p h i a , PA 19104.
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The frequency of gram n e g a t i v e i n f e c t i o n s and endotoxemia i n t h e p e r i n a t a l period prompted an i n v e s t i g a t i o n of t h e e f f e c t s o f endotoxin ( E . so. 02686) on h e p a t i c drug metabolism. Chroni dosing of endotoxin (0.2 mg/kg/d x 7 days) t o l a c t a t i n g mothers s i g n i f i c a n t l y s t i m u l a t e d h e p a t i c microsomal cytochrome P-450 (118%) and aminopyrine demethylase a c t i v i t y (114%). No a l t e r a t i o i n neonatal enzyme a c t i v i t i e s was observed. Body and l i v e r weigh r a t i o s o r microsomal p r o t e i n l e v e l of mothers and neonates were not a l t e r e d by chronic a d m i n i s t r a t i o n of endotoxin t o mothers during t h e experimental p e r i o d . The a c u t e i . p . a d m i n i s t r a t i o n o of endotoxin t o mothers (1.4 mg/kg on t h e 7 t h day a f t e r p a r t u r it i o n ) s i g n i f i c a n t l y decreased t h e a c t i v i t y of aminopyrine demethy a s e (487) and content of cytochrome P-450 (25%). When neonates themselves were i n j e c t e d ( i . p . ) w i t h endotoxin (1.0 mglkg) a t 7 , 16 and 27 days of age, a s i g n i f i c a n t r e d u c t i o n i n l e v e l s of mixe f u n c t i o n oxidase enzymes was observed. Cytochrome P-450 c o n t e n t were reduced by 57, 32 and 24% and aminopyrine demethylation decreased by 78, 48 and 34% i n 7, 16 and 27 day o l d animals r e s p t i v e l y . These o b s e r v a t i o n s i n d i c a t e t h a t t h e a b i l i t y of mothers and neonates t o metabolize drugs i s s i g n i f i c a n t l y decreased upon a c u t e exposure t o endotoxin and t h i s demands c a r e f u l e v a l u a t i o n of drug d i s p o s i t i o n i n gram n e g a t i v e s e p s i s during p e r i n a t a l p e r i o d . Supported by NIH Grant HD 10063.
EFFECT OF ENDOTOXIN ON RAT HEPATIC DRUG METABOLISM DURING DEVELOPMENT. Babasaheb R . Sonawane* and Sumner J. Y a f f e . C h i l d r e n l s H o s p i t a l and Dept. of P e d i a t r i c s , ,
